This study observed decreased TNF-α expression, and reduced proliferation, migration, and invasion in RA-FLSs, with downregulation of NF-kB and NLRP3 inflammasomes following PBM treatment [55]. The gene discussed is NLRP3; the disease is rheumatoid arthritis.